Dual orexin receptor antagonists as promising therapeutics for Alzheimer’s disease

被引：0

作者：

S. M. Ragsdale ^{[1
]}

J. M. Radovich ^{[2
]}

I. I. Coiduras ^{[3
]}

W. V. McCall ^{[1
]}

S. C. Grant ^{[4
]}

C. Lee ^{[2
]}

A. Wilber ^{[3
]}

机构：

[1] Department of Psychology; Program in Neuroscience; Florida State University,Department of Chemical & Biochemical Engineering, FAMU

[2] Florida State University,FSU College of Engineering

[3] Florida State University,CIMAR, National High Magnetic Field Laboratory

[4] Department of Psychiatry and Health Behavior; Medical College of Georgia; Augusta University,Department of Biomedical Sciences; Program in Neuroscience; College of Medicine

[5] Florida State University,undefined

来源：

npj Biological Timing and Sleep | / 2卷 / 1期

关键词：

D O I：

10.1038/s44323-025-00025-5

中图分类号：

学科分类号：

摘要：

We examine the relationship between sleep, glymphatics and Alzheimer’s disease (AD), and recent work questioning glymphatic clearance during sleep. We highlight a need for understanding glymphatic and/or other mechanism of clearance during sleep, and review glymphatic flow measurement methods. Further, we explore dual orexin receptor antagonists (DORAs) potential to mitigate AD sleep disturbances and enhance clearance. Further research could elucidate a linkage between DORAs, improved sleep and reducing AD pathophysiology.

引用

共 50 条

[21] Dual Orexin Receptor Antagonists (DORAs) as an Adjunct Treatment for Smoking Cessation
Hamidovic, Ajna
CNS DRUGS, 2022, 36 (05) : 411 - 417
[22] Proline bis-amides as potent dual orexin receptor antagonists
Bergman, Jeffrey M.
Roecker, Anthony J.
Mercer, Swati P.
Bednar, Rodney A.
Reiss, Duane R.
Ransom, Richard W.
Harrell, C. Meacham
Pettibone, Douglas J.
Lemaire, Wei
Murphy, Kathy L.
Li, Chunze
Prueksaritanont, Thomayant
Winrow, Christopher J.
Renger, John J.
Koblan, Kenneth S.
Hartman, George D.
Coleman, Paul J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (04) : 1425 - 1430
[23] Dual Orexin Receptor Antagonists (DORAs) as an Adjunct Treatment for Smoking Cessation
Ajna Hamidovic
CNS Drugs, 2022, 36 : 411 - 417
[24] Orexin Receptor Antagonists and Insomnia
Xin Wu
Tao Xue
Zhouqing Chen
Zhong Wang
Gang Chen
Current Psychiatry Reports, 2022, 24 : 509 - 521
[25] Selective orexin receptor antagonists
Lebold, Terry P.
Bonaventure, Pascal
Shireman, Brock T.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (17) : 4761 - 4769
[26] Orexin Receptor Antagonists and Insomnia
Wu, Xin
Xue, Tao
Chen, Zhouqing
Wang, Zhong
Chen, Gang
CURRENT PSYCHIATRY REPORTS, 2022, 24 (10) : 509 - 521
[27] Curcumin and Apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease
Venigalla, Madhuri
Sonego, Sandra
Gyengesi, Erika
Muench, Gerald
NEURAL REGENERATION RESEARCH, 2015, 10 (12) : 2017 - 2017
[28] Curcumin and Apigenin – novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease
Madhuri Venigalla
Erika Gyengesi
Gerald Münch
Neural Regeneration Research, 2015, 10 (08) : 1181 - 1185
[29] Curcumin and Apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease
Venigalla, Madhuri
Gyengesi, Erika
Muench, Gerald
NEURAL REGENERATION RESEARCH, 2015, 10 (08) : 1181 - 1185
[30] Brain-Penetrant Tetrahydronaphthalene Thromboxane A2-Prostanoid (TP) Receptor Antagonists as Prototype Therapeutics for Alzheimer's Disease
Soper, James H.
Sugiyama, Shimpei
Herbst-Robinson, Katie
James, Michael J.
Wang, Xiaozhao
Trojanowski, John Q.
Smith, Amos B., III
Lee, Virginia M. -Y.
Ballatore, Carlo
Brunden, Kurt R.
ACS CHEMICAL NEUROSCIENCE, 2012, 3 (11): : 928 - 940

← 1 2 3 4 5 →